Influenza Diagnostics Market is expected to generate a revenue of USD 1.35 Billion by 2028, Globally, at 8.65% CAGR: Verified Market Research®

The prevalence of influenza is increasing globally, along with this, technological advancements creating more accurate and precise diagnostic methods are expected to assist in growing the global Influenza Diagnostics Market.

JERSEY CITY, N.J., Nov. 11, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Influenza Diagnostics Market" By End User(Hospitals/Clinical Laboratories, Reference Laboratories), By Test Type(Traditional diagnostic tests and Molecular Diagnostic tests), By Geographic Scope And Forecast.

As per the deep research carried out by Verified Market Research, the global Influenza Diagnostics Market size was valued at USD 0.70 Billion in 2020 and is projected to reach USD 1.35 Billion by 2028, growing at a CAGR of 8.65% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=24117

Browse in-depth TOC on "Influenza Diagnostics Market"

202 - Pages
126 – Tables
37 – Figures

Global Influenza Diagnostics Market Overview

Influenza is one of the most common forms of illness which is also identified as flu and is caused by the influenza virus. The common symptoms of influenza involve symptoms related to the upper respiratory system. It generally affects individuals with low immunity such as children and elderly patients above the age of 65 years. There are three types of Influenza virus: Type A, Type B, and Type C. Type A virus is much more active than the other two types and poses a greater threat. Influenza diagnostics are useful for end users such as hospitals/clinical laboratories, reference laboratories, and other healthcare organizations.

The prevalence of influenza has increased in recent years, which has led to increased funding for influenza research. This is the primary driver for the global influenza diagnostics market. The demand for advanced and faster diagnostic methods for influenza is expected to drive market growth during the forecast period. The rapidly growing geriatric population globally is another major factor for the growth of the global influenza diagnostics market, as this population is more susceptible to catching influenza infection.

Key Developments

• In July 2018, the Biomedical Advanced Research and Development Authority (BARDA) which is a part of the United Sates Department of Health & Human Services has announced a partnership with Cue Health Inc. and Diassess Inc. The aim of this partnership is to develop testing kits specifically for the influenza diagnosis.
• In January 2021, Mesa Biotech which is a leading developer and manufacturer of next-generation molecular diagnostic tests has been acquired by Thermo Fisher Scientific for the sum of USD 450 million. This acquisition will expand Thermo Fisher Scientific's portfolio of tests as it will add Mesa's PCR-based Accula rapid point-of-care test platform for SARS-CoV-2, RSV, Influenza A and B, and Strep A to Thermo's portfolio.
• In May 2021, FDA approval has been received by Becton, Dickinson, and Company which is a medical technology company for the BD Veritor Plus System. The BD Veritor Plus System will play a vital role in detecting influenza A, influenza B, and SARS-CoV-2.

Key Players

The major players in the market are Hoffmann-La Roche AG, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Alere Inc., Diasorin S.P.A., Quidel Corporation, Meridian Bioscience, Inc., Analytik Jena AG (A Subsidiary of Endress+Hauser AG),Luminex Corporation, SA Scientific, Ltd.

Verified Market Research has segmented the Global Influenza Diagnostics Market On the basis of End User, Test Type, and Geography.

• Influenza Diagnostics Market, By End User
• Hospitals/Clinical Laboratories
• Reference Laboratories
• Other End Users
• Influenza Diagnostics Market, By Test Type
• Traditional diagnostic tests
• Rapid Influenza Detection Tests (RIDT)
• Viral Culture
• Direct Fluorescent Antibody (DFA) Tests
• Serological Assays
• Molecular Diagnostic tests
• RT-PCR
• Nucleic Acid Sequence-Based Amplification (NASBA) Tests
• Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
• Simple Amplification-Based Assays (SAMBA)
• Other Molecular Diagnostic Tests
• Influenza Diagnostics Market, By Geography
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports:

Healthcare Associated Infections Treatment Market By Infection Type (Bloodstream Infections, Ventilator-Associated Pneumonia (VAP)), By Treatment (Antibacterial, Antiviral), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies), By Geography, And Forecast

Anti-Infective Drugs Market By Product (Antibiotics, Antivirals, Antifungals), By Geography, And Forecast

Anti-Retroviral Drugs Market By Type (Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors), By Application (HIV/AIDS, Herpes, Influenza), By Geography, And Forecast

Viral Vaccines Market By Technology (Recombinant & conjugate vaccines, Inactivated vaccines), By Indication (Pneumococcal disease, Meningococcal disease), By Distribution Channel (Hospital pharmacy, Online pharmacy), By End-User (Pediatric, Adult), By Route Of Administration (Oral, Injectable), By Geography, And Forecast

Top 5 Infection Control Companies severancing the contamination internationally

Visualize Influenza Diagnostics Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: [email protected]
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

SOURCE Verified Market Research